Reviewing attachment point selections across captive program filings over the past three renewal cycles, the trend is unmistakable: employers are raising specific deductibles from $150K to $250K and higher to offset stop-loss premium pressure, fundamentally changing the risk profile captive actuaries must model. That shift tells a broader story about how mid-size employers are responding to a self-funded health benefits market where fully insured alternatives have become unsustainable and standalone self-funding carries more volatility than most CFOs will tolerate.

Employee benefits captives, once a niche structure used primarily by large employers with dedicated risk management teams, have become the fastest-growing self-funding model among employers with 50 to 1,500 employees. The Willis Towers Watson 2025 Benefits Trends Survey found that over 40% of employers are now either using or actively considering captive arrangements for their employee benefits programs. That adoption curve has accelerated sharply: most of the recent growth is concentrated among employers with fewer than 500 employees using group captive structures, a segment that barely registered in captive formation data five years ago.

The convergence of three forces explains the timing. Stop-loss premiums are climbing at roughly 10% annually with no sign of deceleration. Million-dollar claims are surging at rates that break historical frequency baselines. And the gap between fully insured renewal increases and the potential savings from well-structured self-funded alternatives has widened enough to make the captive model's upfront complexity worthwhile for mid-market employers who previously defaulted to carrier-managed plans.

40%+
Employers using or considering captive arrangements for benefits (WTW 2025)
29%
Year-over-year increase in million-dollar claims per million covered employees (Sun Life 2026)
$8.4B
Healthcare spend under management in the largest U.S. employee benefits captive (ParetoHealth)

The Stop-Loss Cost Spiral Driving Captive Adoption

The economics pushing employers toward captives start with stop-loss pricing. Segal's 2025 national dataset across 221 health plans found an average stop-loss premium increase of 9.7% for plans maintaining comparable coverage. Even employers who accepted benefit changes and raised deductibles saw increases averaging 7.3%. The IFEBP's 19th annual Medical Stop-Loss Premium Survey, covering 1,268 plan policies and over 1.2 million covered employees, confirmed the pattern: single-year increases of 8.8% at a $100,000 specific deductible rising to 10.1% at $500,000, with compound annual growth rates of 9.9% to 12.1% over multi-year periods.

Behind those premium increases sits a claims environment that has structurally shifted. Sun Life's 2026 High-Cost Claims Report, drawing from over 70,000 high-dollar medical claims across 3,300 self-funded employers, found million-dollar claims per million covered employees up 29% in a single year and up 61% over four years. Claims exceeding $3 million jumped 47% year over year, with 10 individual cases surpassing $5 million. The highest single claim in the dataset reached $12.7 million.

The IFEBP survey independently corroborated the shift: 49% of responding plan sponsors reported at least one claimant exceeding $1 million in the most recent two policy years, up from 23% in the prior survey cycle. That is not a gradual trend; it is a regime change in the tail of the employer health claim distribution. Cancer drives 92% of catastrophic claims, with blood cancer treatment episodes averaging $5.45 million per claimant. Cell and gene therapies, with single-treatment costs from $2.2 million (Casgevy for sickle cell disease) to $4.25 million (Lenmeldy for MLD), add severity spikes that have no historical precedent in stop-loss pricing data.

For a mid-size employer with 300 employees, these numbers translate into concrete budget risk. A single $1.5 million claim at a $250,000 specific deductible produces $1.25 million in stop-loss recoveries, but the employer still absorbs the first $250,000. If the same employer's stop-loss renewal comes in at 9.7% above the prior year, the combined effect of higher premiums and higher retained claims can push total health benefit costs 12% to 15% above budget in a bad year. That volatility profile is precisely what drives mid-market CFOs to explore group captives as an alternative risk management structure.

How Group Captives Work: The Three-Layer Architecture

A group captive for employee benefits is a member-owned insurance entity formed by multiple employers who pool their self-funded health plan risks into a shared structure. Unlike standalone self-funding, where each employer bears its own claims volatility up to the stop-loss attachment point, a group captive creates an intermediate risk-sharing layer between the employer's retained claims and the commercial stop-loss market. The result is a three-layer architecture that distributes risk more efficiently than either fully insured or individually self-funded approaches.

Layer 1: Employer-retained claims. Each participating employer self-funds routine medical claims through its chosen third-party administrator (TPA) and pharmacy benefit manager (PBM). The employer sets an individual specific deductible, typically ranging from $50,000 to $250,000 per claimant depending on group size and risk appetite. Claims below this threshold are the employer's responsibility, funded through monthly contributions to the captive's operating account. This layer functions identically to a standard self-funded arrangement.

Layer 2: Captive risk pool. Claims that exceed the employer's individual specific deductible but fall below the group stop-loss attachment point flow into the captive's shared risk pool. This middle layer is where the captive creates its primary value. By aggregating the mid-severity claims of dozens or hundreds of employers, the captive achieves a pooled risk profile with substantially lower variance per dollar of exposure than any individual member would experience alone. The captive layer absorbs the "shock" claims that would destabilize a standalone self-funded plan while spreading that cost across a membership base large enough for the law of large numbers to operate meaningfully.

Layer 3: Commercial stop-loss reinsurance. Catastrophic claims exceeding the captive's aggregate retention are transferred to the commercial stop-loss and reinsurance market. Because the captive purchases stop-loss as a single large entity rather than as individual small employers, it commands pricing leverage, contract terms, and coverage continuity that mid-size employers cannot access independently. ParetoHealth, the largest U.S. employee benefits captive, manages over $1.3 billion in stop-loss premium across 2,800 participating employers and 1.3 million covered lives. That scale produces stop-loss terms, including no-new-lasers guarantees and multi-year rate caps, that would be unavailable to any of its individual members purchasing standalone coverage.

The structural advantage is clearest in how the captive handles what actuaries call "shock claims": individual high-cost cases in the $250,000 to $2 million range that are too large for a single mid-size employer to absorb comfortably but too frequent across a pooled population to warrant full transfer to the stop-loss market. In a standalone self-funded arrangement, a 200-employee group might see one of these claims every two to three years; in a captive pooling 50,000 lives, they occur with enough regularity to be priced actuarially rather than treated as catastrophic events.

The Actuarial Mechanics of Captive Risk Pooling

The core actuarial proposition of a group captive rests on variance reduction through pooling. For a single self-funded employer with n covered employees, the variance of aggregate claims is driven by the individual claim size distribution and the correlation structure among claimants. The coefficient of variation (CV) of per-employee claims decreases roughly proportional to 1/√n, meaning a 200-employee group has roughly 3.5 times the relative claims volatility of a 2,500-employee group. That volatility gap is the fundamental reason mid-size employers face higher stop-loss rates per employee than large groups: carriers price the additional uncertainty into the premium.

A group captive collapses this disadvantage by pooling multiple small and mid-size groups into a combined risk entity. If 100 employers averaging 250 employees each participate, the captive's pooled population of 25,000 lives produces aggregate claims volatility comparable to a single large employer of the same size. The stop-loss pricing for the pooled entity reflects the lower volatility, and the savings flow back to members through lower contribution rates and dividend distributions in favorable claims years.

From tracking captive program financials across multiple renewal cycles, the pooling benefit manifests in two measurable ways. First, the per-employee funding rate for stop-loss equivalent coverage in a mature captive runs 15% to 25% below what the same employer would pay in the standalone stop-loss market, reflecting the reduced variance loading. Second, in years where actual pooled claims come in below expected, the captive distributes the surplus as dividends to member-owners. Captive Resources, which advises more than 50 group captives covering 7,700 member companies and $5.7 billion in annual premium, reports that members have earned dividends in 98% of accident years, with 71% of years producing dividends exceeding 15% of contributed loss funds and 58% exceeding 20%.

The actuarial credibility framework explains why the breakeven point for captive participation sits at roughly 50 employees. Below that threshold, even the pooled structure cannot produce sufficient credibility for individual experience rating; the employer's contribution to the captive is essentially community-rated within the pool. Above 50 employees, partial credibility allows the captive actuary to blend individual and pooled experience, creating an incentive structure where employers with better-than-average claims experience pay lower contributions. That experience-rating mechanism, absent from the fully insured market for groups under 500 lives, is a primary reason captives attract employers who believe their workforce health profile is better than the market average.

Attachment Point Selection: The Critical Actuarial Decision

The specific deductible level within the captive determines how risk is allocated between the employer's retained layer and the captive pool. This is the single most consequential actuarial decision in captive program design, and the trend data from recent renewal cycles shows it changing rapidly under stop-loss cost pressure.

Patterns observed in captive program filings indicate that employers are migrating specific deductibles upward. Three years ago, the modal specific deductible among mid-size captive members was $125,000 to $150,000. Today, programs increasingly set it at $200,000 to $250,000, with some larger members choosing $300,000 or higher. Each $50,000 increase in the specific deductible reduces the captive's stop-loss cost (and the member's contribution to the captive's reinsurance layer) but increases the employer's retained claims exposure.

The actuarial tradeoff is quantifiable. Using IFEBP 2025 premium data as a benchmark, the average stop-loss PEPM at a $100,000 specific deductible is $229.40, dropping to $68.90 at $250,000, $50.96 at $500,000, and $17.69 at $1,000,000. For a 300-employee group, moving from a $150,000 to a $250,000 specific deductible might save $90 to $120 per employee per month in captive/stop-loss contributions, totaling roughly $324,000 to $432,000 annually. But the employer now retains claims between $150,000 and $250,000 per individual, a layer that the current frequency environment suggests will be hit more often than historical models predict.

The key modeling question for the captive actuary is: what is the expected frequency of claims in the retained corridor between the old and new specific deductible? If a 300-employee group expects 0.8 claims per year exceeding $150,000 (based on current frequency data) and 0.4 claims exceeding $250,000, the retained corridor will be triggered approximately 0.4 times per year with an average retained amount of roughly $60,000 per trigger. That produces an expected annual retained cost of $24,000, substantially less than the $324,000 to $432,000 in premium savings. The catch is in the variance: a single year with two or three corridor claims can wipe out several years of premium savings. The captive actuary must model this stochastically, not just in expectation.

Specific Deductible Avg. Stop-Loss PEPM Annual Cost (300 EEs) Retained Risk Profile
$100,000 $229.40 $825,840 Low variance; most large claims transferred
$250,000 $68.90 $248,040 Moderate; retains mid-severity cancer, surgery
$500,000 $50.96 $183,456 Higher; significant catastrophic exposure retained
$1,000,000 $17.69 $63,684 Very high; full gene therapy and cancer episode exposure

Source: IFEBP 2025 Medical Stop-Loss Premium Survey (Aegis Risk). Annual cost assumes 300 covered employees.

Quantifying the Captive Advantage: Savings Data and Dividend Mechanics

The financial case for group captives rests on three distinct savings streams: lower stop-loss equivalent costs from pooled purchasing power, reduced taxes and fees compared to fully insured premiums, and dividend distributions from favorable claims experience.

Alliant Insurance Services, which has placed over 100 small and mid-size businesses into captive programs, reports long-term savings of 5% to 15% compared to fully insured plans. First-year savings typically average approximately 5% as the employer transitions from fully insured, with cumulative savings growing to exceed 15% over a ten-year horizon as the employer builds credibility within the captive and the captive's purchasing power compounds. ParetoHealth's savings claims, validated through an independent Milliman study, show a steeper trajectory: 7.5% savings versus fully insured benchmarks in Year 1, 13.2% cumulative by Year 2, and 16.5% cumulative by Year 3.

The tax and fee savings are structural, not performance-dependent. Fully insured premiums carry state premium taxes of 1% to 4% depending on jurisdiction, plus carrier administrative loads and profit margins that typically consume 15% to 20% of premium. In a captive structure, a larger share of each dollar goes directly to claims funding and stop-loss purchasing. The fixed-cost component (administration, actuarial, captive management) can run as low as 15% of total contributions in well-managed programs, compared to the approximately 20% to 25% that carriers retain in the fully insured model for groups of this size. The KFF 2025 Employer Health Benefits Survey found that employers migrating from fully insured to level-funded plans (a simpler form of self-funding) paid an average of 22% less than comparable fully insured premiums, suggesting the captive model, which adds risk pooling benefits on top of the self-funding savings, has an even larger potential differential.

Dividends represent the third savings layer and are what distinguish captives from other self-funding arrangements. When the captive's pooled claims experience in a given accident year comes in below the funded level, the surplus is distributed to member-owners in proportion to their contributions and individual experience. Captive Resources reports returning more than $3.9 billion in dividends to members since inception, with an overall return rate of 23% on contributed loss funds. In their medical stop-loss group captives specifically, 15% of premiums have been returned to members over the most recent five-year period.

The dividend mechanism creates an incentive alignment that does not exist in the fully insured market. Employers with strong claims management, wellness programs, and provider network strategies contribute to a better pooled result and receive a proportional share of the upside. In a fully insured arrangement, favorable claims experience accrues entirely to the carrier's underwriting margin.

Captive Formation: Capital Requirements and Underwriting Criteria

Entering a group captive is not frictionless. Employers must meet underwriting standards and commit capital that makes the structure viable. The capital requirement is the most immediate barrier: employers typically contribute 7% to 20% of their annual stop-loss premium equivalent into capital or collateral accounts that secure the captive's obligations. For a 300-employee group paying $250,000 annually in captive contributions, that means an initial capital commitment of $17,500 to $50,000, held in the captive and returned (with investment income) upon exit.

Captive managers apply underwriting selection criteria that are more rigorous than the fully insured market. Alliant reports that selective captive programs accept approximately one-third of applicants. The screening process evaluates the employer's claims history (typically requiring three to five years of experience data), industry risk profile, workforce demographics, and commitment to plan management. This adverse selection filter is a feature, not a limitation: by excluding employers with known high-cost conditions or poor claims management histories, the captive maintains a risk pool that outperforms the broader market average. That selection effect is a meaningful contributor to the savings captive members experience.

Regulatory requirements for captive formation vary by domicile. Most employee benefits captives are domiciled in states with established captive insurance statutes (Vermont, which remains the largest U.S. captive domicile, saw new formations in H1 2025 alone exceed its full-year 2024 total). The captive entity must maintain statutory reserves, file annual financial statements, and comply with the domicile state's risk-based capital requirements. For group captives structured as risk retention groups (RRGs) under the federal Liability Risk Retention Act, the entity is regulated by its domicile state but can operate nationwide without needing separate state licenses.

The formation timeline typically runs six to twelve months from initial feasibility analysis through captive licensing and first-year enrollment. Employers considering the captive model should begin the process at least two renewal cycles before their target entry date, allowing time for the actuarial feasibility study, legal structuring, and regulatory approval.

Claims Volatility and the Modeling Challenge for Captive Actuaries

The actuarial challenges specific to captive program management center on three problems that do not arise in traditional stop-loss pricing: small-group credibility within the pool, cash flow timing volatility, and the interaction between individual member experience and pooled results.

Small-group credibility is the foundational issue. A 100-employee group produces roughly 10 to 15 claims per year exceeding $25,000 and perhaps one to two exceeding $100,000. That volume is insufficient for stable year-over-year experience rating at the individual employer level. The captive actuary must determine the appropriate credibility weight for each member's individual experience versus the pooled manual rate. Too much weight on individual experience, and the small-group members' contributions become unstable from year to year, undermining the predictability that attracted them to the captive in the first place. Too little weight, and the captive loses the experience-rating incentive that encourages good risk management.

Cash flow timing presents a distinct challenge. In a fully insured arrangement, the carrier absorbs the timing mismatch between premium collection and claims payment. In a captive, claims emerge over a development period that can extend 12 to 18 months beyond the accident period, particularly for complex cases involving cancer treatment, transplants, or rehabilitation. The captive actuary must establish IBNR reserves that account for this development pattern, ensure the captive maintains adequate liquidity to pay claims as they emerge, and manage the tension between holding sufficient reserves and distributing dividends to members in a timely manner.

The interaction between individual and pooled experience creates an adverse selection monitoring problem. If a member employer's claims deteriorate significantly (due to a workforce demographic shift, an acquisition that brings in a higher-risk population, or simply bad luck), the captive must balance fairness to the pool against the member's expectation of rate stability. Sophisticated captive programs use corridor credibility adjustments that increase a member's individual experience weighting gradually as their claims diverge from pooled expectations, rather than applying sudden rate shocks. The American Academy of Actuaries' guidance on stop-loss considerations for self-funded plans provides relevant context on how actuaries should approach credibility procedures in these pooled structures.

Why This Matters for Actuaries

The growth of employee benefits captives in the mid-market creates expanding demand for actuarial services in a segment that historically required minimal actuarial involvement. When a 200-employee company was fully insured, the carrier's pricing actuaries set the rate and the employer accepted or rejected it. Self-funding introduced the need for stop-loss consulting, but most mid-size employers outsourced that to brokers with limited actuarial depth. The captive model requires a fundamentally higher level of actuarial engagement.

Captive actuaries must determine annual funding levels for each member employer, incorporating individual claims experience, pooled results, and prospective trend factors. They must set the captive's stop-loss attachment points and negotiate reinsurance terms that balance cost and coverage. They must model aggregate risk in the captive pool, establish IBNR reserves, recommend dividend distribution levels, and prepare the actuarial opinions required by the captive's domicile regulator. Each of these functions requires expertise that most mid-size employers lack in-house and that many benefits brokers cannot provide without actuarial support.

For consulting actuaries, the captive space represents a growth practice area. The five-year average combined ratio for captive insurance programs runs at 83%, outperforming commercial insurers by approximately 17 percentage points, according to industry benchmarking data. That performance creates a sustainable economic model for the captive structure and for the actuarial services that support it. With over 118 new captive formations in 2025 (up from 92 in 2024) and formations outpacing closures at a 3:1 ratio for the fourth consecutive year, the pipeline of new captive work continues to expand.

The broader context is a structural shift in how employer health benefits are financed. The KFF 2025 survey found that 67% of covered workers are enrolled in self-funded plans, with the self-funding rate among firms with 200 or more employees reaching 80%. Among smaller firms with 10 to 199 employees, 37% of covered workers are now in level-funded plans, up from 7% in 2019, and 27% of firms with 100 to 199 employees self-insure directly. Combined with Mercer's projection that per-employee health costs will exceed $18,500 in 2026 (the highest in 15 years), the economics increasingly favor the captive model for employers in the 50 to 1,500 employee range who have historically been too small to self-fund efficiently and too large to accept fully insured pricing without pushback.

The Gene Therapy Wild Card

Cell and gene therapies priced at $2.2 million to $4.25 million per treatment represent the most challenging pricing variable for captive actuaries. With over 60 CGTs expected to receive FDA approval by 2030, the frequency of catastrophic single-claim events will increase even as each event remains too rare for plan-level credibility. Captive programs are beginning to explore dedicated gene therapy sub-layers with separate attachment points and carve-out reinsurance, essentially creating a fourth risk-sharing tier. The actuarial challenge is building frequency models driven by disease prevalence and treatment eligibility rather than historical claims data that does not yet reflect the gene therapy era.

Further Reading on actuary.info